111 related articles for article (PubMed ID: 11784550)
1. Alzheimer's disease. Unravelling the disease process.
George-Hyslop PS; Rossor M
Lancet; 2001 Dec; 358 Suppl():S1. PubMed ID: 11784550
[No Abstract] [Full Text] [Related]
2. Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.
Allué JA; Sarasa L; Izco M; Pérez-Grijalba V; Fandos N; Pascual-Lucas M; Ogueta S; Pesini P; Sarasa M
J Alzheimers Dis; 2016 May; 53(3):773-85. PubMed ID: 27258422
[TBL] [Abstract][Full Text] [Related]
3. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
[TBL] [Abstract][Full Text] [Related]
4. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.
Takeuchi A; Irizarry MC; Duff K; Saido TC; Hsiao Ashe K; Hasegawa M; Mann DM; Hyman BT; Iwatsubo T
Am J Pathol; 2000 Jul; 157(1):331-9. PubMed ID: 10880403
[TBL] [Abstract][Full Text] [Related]
5. Biological transgenic mouse models of Alzheimer's disease.
Crews L; Rockenstein E; Masliah E
Handb Clin Neurol; 2008; 89():291-301. PubMed ID: 18631753
[No Abstract] [Full Text] [Related]
6. Study on Aβ34 biology and detection in transgenic mice brains.
Caillava C; Ranaldi S; Lauritzen I; Bauer C; Fareh J; Abraham JD; Checler F
Neurobiol Aging; 2014 Jul; 35(7):1570-81. PubMed ID: 24495834
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase.
Yang H; Zhuo JM; Chu J; Chinnici C; Praticò D
Biol Psychiatry; 2010 Nov; 68(10):922-9. PubMed ID: 20570249
[TBL] [Abstract][Full Text] [Related]
8. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
9. [Beta/A4-type amyloid protein in Alzheimer's disease and cerebral amyloid angiopathies].
Hirai S; Okamoto K
Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1424-9. PubMed ID: 8245639
[No Abstract] [Full Text] [Related]
10. Late age increase in soluble amyloid-beta levels in the APP23 mouse model despite steady-state levels of amyloid-beta-producing proteins.
Janssen L; Keppens C; De Deyn PP; Van Dam D
Biochim Biophys Acta; 2016 Jan; 1862(1):105-12. PubMed ID: 26542217
[No Abstract] [Full Text] [Related]
11. Progranulin haploinsufficiency reduces amyloid beta deposition in Alzheimer's disease model mice.
Hosokawa M; Tanaka Y; Arai T; Kondo H; Akiyama H; Hasegawa M
Exp Anim; 2018 Feb; 67(1):63-70. PubMed ID: 28845019
[TBL] [Abstract][Full Text] [Related]
12. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
13. Nitrosylation of Vesicular Transporters in Brain of Amyloid Precursor Protein/Presenilin 1 Double Transgenic Mice.
Wang Y; Zhou Z; Tan H; Zhu S; Wang Y; Sun Y; Li XM; Wang JF
J Alzheimers Dis; 2017; 55(4):1683-1692. PubMed ID: 27911305
[TBL] [Abstract][Full Text] [Related]
14. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
15. [Problems of the amyloid beta precursor protein in pathogenesis of the Alzheimer type dementia].
Shoji M; Hirai S
Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):164-8. PubMed ID: 8648890
[No Abstract] [Full Text] [Related]
16. The FAM3 superfamily member ILEI ameliorates Alzheimer's disease-like pathology by destabilizing the penultimate amyloid-β precursor.
Hasegawa H; Liu L; Tooyama I; Murayama S; Nishimura M
Nat Commun; 2014 Jun; 5():3917. PubMed ID: 24894631
[TBL] [Abstract][Full Text] [Related]
17. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
[TBL] [Abstract][Full Text] [Related]
18. AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
Bielarczyk H; Jankowska-Kulawy A; Höfling C; Ronowska A; Gul-Hinc S; Roßner S; Schliebs R; Pawelczyk T; Szutowicz A
J Alzheimers Dis; 2015; 48(4):1083-94. PubMed ID: 26402099
[TBL] [Abstract][Full Text] [Related]
19. Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies.
Szczygielski J; Mautes A; Steudel WI; Falkai P; Bayer TA; Wirths O
J Neural Transm (Vienna); 2005 Nov; 112(11):1547-64. PubMed ID: 15959838
[TBL] [Abstract][Full Text] [Related]
20. Endogenous murine Aβ increases amyloid deposition in APP23 but not in APPPS1 transgenic mice.
Mahler J; Morales-Corraliza J; Stolz J; Skodras A; Radde R; Duma CC; Eisele YS; Mazzella MJ; Wong H; Klunk WE; Nilsson KPR; Staufenbiel M; Mathews PM; Jucker M; Wegenast-Braun BM
Neurobiol Aging; 2015 Jul; 36(7):2241-2247. PubMed ID: 25911278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
